PTGER4 and neoplasm: This is concordant with PGE2 being the major prostanoid in tumor microenvironments [6, 48] and fits previous observations in ApcMin transgenic mice, where deletion of PTGER1, PTGER2, and PTGER4 inhibits the development of CRC [49–51].